Protoporphyrin Treatment Modulates Susceptibility to Experimental Autoimmune Encephalomyelitis in miR-155-Deficient Mice

被引:7
|
作者
Zhang, Jinyu [1 ]
Braun, Michel Y. [2 ]
机构
[1] Third Mil Med Univ, Coll Pharm, Natl Engn Res Ctr Immunol Prod, Dept Microbiol & Biochem Pharm, Chongqing, Peoples R China
[2] Univ Libre Bruxelles, Fac Med, Inst Med Immunol, Gosselies, Belgium
来源
PLOS ONE | 2015年 / 10卷 / 12期
关键词
HEME OXYGENASE-1; INFLAMMATION; INHIBITION;
D O I
10.1371/journal.pone.0145237
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We previously identified heme oxygenase 1 (HO-1) as a specific target of miR-155, and inhibition of HO-1 activity restored the capacity of miR-155(-/-)CD4(+) T cells to promote antigendriven inflammation after adoptive transfer in antigen-expressing recipients. Protoporphyrins are molecules recognized for their modulatory effect on HO-1 expression and function. In the present study, we investigated the effect of protoporphyrin treatment on the development of autoimmunity in miR-155-deficient mice. MiR-155-mediated control of HO-1 expression in promoting T cell-driven chronic autoimmunity was confirmed since HO-1 inhibition restored susceptibility to experimental autoimmune encephalomyelitis (EAE) in miR-155deficient mice. The increased severity of the disease was accompanied by an enhanced T cell infiltration into the brain. Taken together, these results underline the importance of miR155-mediated control of HO-1 expression in regulating the function of chronically-stimulated T cells in EAE.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] PD-1 deletion restores susceptibility to experimental autoimmune encephalomyelitis in miR-155-deficient mice
    Zhang, Jinyu
    Braun, Michel Y.
    INTERNATIONAL IMMUNOLOGY, 2014, 26 (07) : 407 - 415
  • [2] miR-155-Deficient Bone Marrow Promotes Tumor Metastasis
    Yu, Fang
    Jia, Xuemei
    Du, Fen
    Wang, Junfeng
    Wang, Yuzhen
    Ai, Walden
    Fan, Daping
    MOLECULAR CANCER RESEARCH, 2013, 11 (08) : 923 - 936
  • [3] Experimental autoimmune encephalomyelitis in histidine decarboxylase deficient mice
    Pedotti, R
    Musio, S
    Scabeni, S
    Gallo, B
    Poliani, PL
    Ohtsu, H
    Mantegazza, R
    JOURNAL OF NEUROLOGY, 2004, 251 : 51 - 51
  • [4] Experimental autoimmune encephalomyelitis in histidine decarboxylase-deficient mice
    Pedotti, R
    Musio, S
    Scabeni, S
    Gallo, B
    Poliani, L
    Ohtsu, H
    Mantegazza, R
    JOURNAL OF NEUROIMMUNOLOGY, 2004, 154 (1-2) : 53 - 53
  • [5] Experimental autoimmune encephalomyelitis in IL-4-deficient mice
    Liblau, R
    Steinman, L
    Brocke, S
    INTERNATIONAL IMMUNOLOGY, 1997, 9 (05) : 799 - 803
  • [6] EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS IN MICE - GENETIC-CONTROL OF SUSCEPTIBILITY
    BERNARD, CCA
    JOURNAL OF IMMUNOGENETICS, 1976, 3 (04): : 263 - 274
  • [7] Acamprosate modulates experimental autoimmune encephalomyelitis
    Sternberg Z.
    Cesario A.
    Rittenhouse-Olson K.
    Sobel R.A.
    Pankewycz O.
    Zhu B.
    Whitcomb T.
    Sternberg D.S.
    Munschauer F.E.
    Inflammopharmacology, 2012, 20 (1) : 39 - 48
  • [8] CD73-deficient mice are resistant to experimental autoimmune encephalomyelitis
    Bynoe, Margaret S.
    Mills, Jeffrey
    Thompson, Linda F.
    JOURNAL OF IMMUNOLOGY, 2007, 178
  • [9] Reduced Severity of Experimental Autoimmune Encephalomyelitis in GMF-Deficient Mice
    Asgar Zaheer
    Smita Zaheer
    Shailendra K. Sahu
    Baoli Yang
    Ramon Lim
    Neurochemical Research, 2007, 32 : 39 - 47
  • [10] Experimental autoimmune encephalomyelitis in costimulatory molecule deficient NOD mice.
    Girvin, AM
    Bluestone, JA
    Miller, SD
    FASEB JOURNAL, 1999, 13 (04): : A287 - A287